Voloridge Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Voloridge Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,174	Closed	-$716K	–	1598
2020 Q1	$716K	Sell	8,174 -12,309	-60%	-$1.3M	0.02%	604
2019 Q4	$2.14M	Buy	20,483 +2,053	+11%	+$230K	0.04%	476
2019 Q3	$2.12M	Buy	18,430 +15,906	+630%	+$2.41M	0.04%	437
2019 Q2	$435K	Sell	2,524 -23,822	-90%	-$4.12M	0.01%	588
2019 Q1	$4.44M	Buy	+26,346	New	+$3.92M	0.13%	156
2018 Q3	–	Sell	-38,623	Closed	-$5.39M	–	518
2018 Q2	$5.39M	Buy	+38,623	New	+$5.49M	0.14%	151
2017 Q3	–	Sell	-8,598	Closed	-$862K	–	576
2017 Q2	$862K	Sell	8,598 -37,010	-81%	-$3.98M	0.02%	333
2017 Q1	$5.52M	Buy	45,608 +9,979	+28%	+$1.22M	0.13%	186
2016 Q4	$3.98M	Buy	+35,629	New	+$4.29M	0.09%	294

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Voloridge Investment Management's GWPH Position: Q2 2020 in Review

Voloridge Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 8,174 shares — an estimated $716K sold.

Voloridge Investment Management first reported a position in GWPH in Q4 2016 and held it in 9 quarters. The position peaked at $5.52M in Q1 2017. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

Voloridge Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Voloridge Investment Management sold 8,174 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $716K.
Voloridge Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 9 quarters.
Voloridge Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $5.52M in Q1 2017.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Voloridge Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.